Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thrombocythemia, Essential × Thalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 36 Neoplasms, Plasma Cell 12 Prostatic Neoplasms 4 Neoplasms 3 Lymphoma, Mantle-Cell 3 Immunoglobulin Light-chain Amyloidosis 3 Central Nervous System Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Amyloidosis 2 Adenocarcinoma of Lung 2 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Polyneuropathies 1 Paraproteinemias 1 Neurotoxicity Syndromes 1 Motor Activity 1

Interventions

fludarabine phosphate 15 Whole-Body Irradiation 9 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 Cyclophosphamide 8 Busulfan 8 Tacrolimus 7 Cyclosporine 5 fludarabine 4 Methotrexate 4 Antilymphocyte Serum 4 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 ruxolitinib 2 peginterferon alfa-2a 2 givinostat hydrochloride 2 givinostat 2 Radiotherapy 2 Melphalan 2 Etoposide 2 Carboplatin 2 veliparib 1 thymoglobulin 1 sonidegib 1 pomalidomide 1 merphos 1 bomedemstat 1 anagrelide 1 Transplantation 1 Topotecan 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡